MedPharm is committed to collaborative, transparent relationships, recognizing that successful partnerships extend beyond mere manufacturing. Our comprehensive technical expertise in topical and transdermal drug delivery and semi-solid formulations, providing robust process development, analytical capabilities, and scalable manufacturing. Adherence to stringent quality and compliance standards is paramount, with a proven track record of regulatory compliance and robust quality systems ensuring consistent product quality. Medpharm's flexibility and adaptability cater to the dynamic nature of drug development, offering project customization and capacity management to address evolving needs and fluctuating volumes. Strong project management practices, clear communication channels, and proactive updates ensure projects remain on track. Medpharm delivers exceptional value through transparent pricing and a comprehensive value proposition that emphasizes expertise, innovation, and reliability. As a reliable partner, Medpharm can seamlessly manage your drug development process from early stages to commercialization, maintaining high-quality standards and meeting specific project timelines and goals through a focus on collaboration and value delivery. Let's talk at DCAT! #CDMO #topical #DCAT #transdermal #MedPharm #commercialmanufacturing #earlystagedevelopment
MedPharm
Pharmaceutical Manufacturing
Durham, North Carolina 15,447 followers
Topical Solutions At Every Stage.
About us
Bringing a groundbreaking topical or transepithelial therapy from concept to patient is no small feat. The journey is complex, filled with challenges like regulatory hurdles, market dynamics, and scientific unpredictability. That’s where MedPharm comes in. As the global gold standard in topical and transepithelial drug development and manufacturing, MedPharm is exclusively dedicated to transforming innovative ideas into successful therapies. With a specialized focus, we partner with pharmaceutical companies to streamline every stage of the drug development pipeline—from formulation and preclinical research to clinical trial material manufacturing and full-scale commercial production. Our expertise is grounded in decades of proven success. Through cutting-edge research methods, a deep understanding of regulatory landscapes, and an unwavering commitment to quality, MedPharm delivers tailored solutions that anticipate and adapt to the evolving needs of our clients. When you partner with MedPharm, you gain more than a CDMO—you gain a trusted ally committed to your success, ensuring your product reaches its full potential in the hands of patients worldwide. MedPharm: Advancing Topical and Transepithelial Therapies, Every Step of the Way.
- Website
-
http://www.medpharm.com
External link for MedPharm
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
- Founded
- 1999
- Specialties
- Topical and transdermal formulation development, GMP Clinical Trial Supply manufacture, Topical and transdermal drug delivery technology, Clinical Development Manufacturing Organization, IVPT/IVRT, Hormone Development, Hormone Manufacture, High Potency Capabilities, CDMO, CMO, Mucosal Drug Dev and Testing, Nasal cast models, Small Molecule, Patent Work, Semi-Solids, Dermal Delivery Services, Formulation topical North Caroline, Topical CDMO, Topical Nail Performance Testing, Ungual Delivery, Otic Product manufacturing, Otic Delivery formulation, Pharmaceutical Disease Activity Models, and Pharmaceutical Performance Testing Services
Locations
-
Primary
4018 Stirrup Creek Dr
Durham, North Carolina 27703, US
-
Unit 3 Chancellor Court
50 Occam Road
Guildford, Surrey GU2 7YN, GB
-
4222 Emperor Blvd
Durham, North Carolina 27703, US
Employees at MedPharm
-
Amit Patel
Board Member. Former CEO. Investor.
-
Gary Gilliam
CEO & President, MedPharm Consulting, Inc, Philanthropist and Life Sciences and Devices Quality and Regulatory Consulting
-
Jon Lenn
Innovative Science Leader | Driving Research Excellence and Bridging Discovery to Market Success
-
Stephanie Proesel, MBA
Driving Growth in Topical Dermatology & Transdermal Solutions | Strategic Partnerships | Innovation & Leadership
Updates
-
Exciting Leadership News at MedPharm! We are thrilled to welcome Bill Humphries as MedPharm’s new Chief Executive Officer! With decades of leadership experience in the pharmaceutical industry and a proven track record of driving strategic growth, Bill is the perfect leader to guide MedPharm into its next phase of innovation and expansion. As a world-class CDMO specializing in topical and transdermal drug development, MedPharm is committed to delivering cutting-edge solutions from formulation development through commercial manufacturing. Bill’s expertise will be instrumental as we continue to elevate our services, expand our capabilities, and reinforce our position as the go-to partner for topical and transdermal product development. Welcome to the team, Bill! We’re excited for what’s ahead. 🔗 Read the full announcement here: https://lnkd.in/ezzMNKS8 #MedPharm #CDMO #Pharma #Leadership #TopicalDrugDevelopment #PharmaceuticalInnovation
-
If you are headed to San Francisco, we can't wait to meet you! #AID2025 #DermatologyInnovation #MedPharm #CDMO #JPM #DermSummit2025
-
-
We’re excited to announce that MedPharm has officially joined DCAT! We look forward to connecting, collaborating, and contributing to the DCAT community as we continue advancing innovative pharmaceutical development solutions. Thank you, DCAT, for the warm welcome! #DCATMember #PharmaInnovation #MedPharm
We are pleased to welcome Fagron, JGL d.d., Ingenza Ltd., MedPharm, Pharmaworks, and Benuvia Operations, LLC. to our DCAT Member Community. See a list of all DCAT Member Companies in the DCAT Member Directory: https://lnkd.in/eEmTB_Q2
-
-
BIO Europe Fall starts next week! It's not too late to reach out through our website or in the event platform to schedule a time to meet with @Kasia Niemiec and @Charles Evans during the event. https://hubs.la/Q02VhDbJ0 https://hubs.la/Q02VhD600
-
-
We are thrilled to add Vincent Avery, MBA to our team--welcome to MedPharm!
I’m honored to announce that I’ve joined MedPharm as the Director of Business Development. In this new chapter, I’ll be focusing on expanding our partnerships and creating value-driven opportunities within the Life Sciences industry, specifically dermatology. I look forward to collaborating with the amazing team at MedPharm and helping our clients achieve their development and manufacturing goals. Thank you to everyone who has supported me along the way—exciting times are ahead! Let’s connect if you’d like to discuss opportunities or just catch up!
This content isn’t available here
Access this content and more in the LinkedIn app
-
Next month, MedPharmer @Kasia Niemiec will be in Stockholm, Sweden for BIO Europe Fall. Send her a message in the event platform to schedule a time to catch up, and comment below if we'll see you there! https://hubs.la/Q02PwMDK0
-
-
MedPharm's Kasia Niemiec, Charles Evans, and Stephanie Proesel, MBA are ready to do business at CPhI Milan. They are looking forward to meeting with current and prospective clients to discuss how MedPharm can help drive their topical, transdermal, and transepithelial drug products forward.
-